CV
Clarus Ventures Portfolio holdings
AUM
$425M
This Quarter Return
+33.01%
1 Year Return
+28.76%
3 Year Return
+73.84%
5 Year Return
+169.94%
10 Year Return
–
AUM
$281M
AUM Growth
+$281M
(+188%)
Cap. Flow
+$25.5M
Cap. Flow
% of AUM
9.08%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
2
Increased
–
Reduced
1
Closed
–
Top Buys
| 1 |
TECX
Tectonic Therapeutic, Inc. Common Stock
TECX
|
$84.6M |
| 2 |
FTSV
Forty Seven, Inc. Common Stock
FTSV
|
$61.1M |
Top Sells
| 1 |
ESSA Pharma
EPIX
|
$120M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TECX
1
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
| $84.6M | 30.09% | +2,962,325 | New | +$84.6M |
|
|
FTSV
2
DELISTED
Forty Seven, Inc. Common Stock
FTSV
| $61.1M | 21.72% | +3,816,951 | New | +$61.1M |
|
|
NSTG
3
DELISTED
NanoString Technologies, Inc.
NSTG
| $54.2M | 19.27% | 3,959,440 | – | – |
|
|
SIEN
4
DELISTED
Sientra, Inc.
SIEN
| $53.3M | 18.95% | 2,730,765 | – | – |
|
5
Venus Concept
VERO
$4.11M
| $12.4M | 4.41% | 3,569,986 | – | – |
|
|
VBIV
6
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $7.4M | 2.63% | 2,691,042 | – | – |
|
|
7
ESSA Pharma
EPIX
$11.4M
| $6.32M | 2.25% | 1,668,560 -31,702,652 | -95% | -$120M |
|
8
Astria Therapeutics
ATXS
$349M
| $1.93M | 0.68% | 2,008,192 | – | – |
|